W.065Akamai plans $2.2B of convertible notes for its cloud build as S&P cuts it below investment grade. Its 2026 capex guidance is more than four times 2025’s
Akamai proposed $2.2B of convertible notes on November 9 to repay part of its notes due next year and fund its Cloud Infrastructure Services build. The same day S&P cut its rating to BB+, below investment grade, and Moody’s cut it to Baa3. Akamai expects capital spending of $3.46B–3.66B this year, 4.2–4.5 times the $818M it spent in 2025 and about 78%–82% of the revenue it guides to, much of it for contracts led by an $11.6B, seven-year commitment from Anthropic.
What was announced
Two series of notes, sized before pricing. Akamai proposed $1,100M of notes due November 2028 and $1,100M due November 2031, with an option for the initial purchasers to buy up to $150M more of each. The interest rate and conversion price are to be set at pricing. Proceeds would go to repaying part of the $1,150M of 0.375% notes due September 2027, to the capital needs of the Cloud Infrastructure Services (CIS) business, to hedge and warrant trades that limit dilution, and to general purposes. The same filing shows that on November 5 Akamai’s banks raised the maximum leverage ratio in its credit agreement to 6.25 times for the next two quarters, stepping down to 3.75 times by early 2028.
The ratings moved the same day. S&P lowered Akamai to BB+ from BBB- and expects leverage slightly above four times in 2027 and more than $1B of negative free operating cash flow, in total, through 2029, Investing.com reported. Moody’s cut it one notch to Baa3, its lowest investment-grade rating, and put pro forma gross leverage above seven times before cash. On its November 5 call, the chief financial officer said the goal was to keep an investment-grade rating “as long as we certainly can.” Investing.com’s quote showed the shares at $80.29, down 3.4% on the day; we could not confirm a closing price.
Akamai’s fourth-quarter capex guidance is about what it spent from January 2024 to September 2026, $2.51B
Capital spending, accrual basis, $ billions. 2026 combines reported spending for the first three quarters (grey) with the chief financial officer’s fourth-quarter range (solid to the low end, dashed to the high end). The dashed line is the midpoint of 2026 revenue guidance. About $1.7B of the fourth quarter is to pre-buy components, notably memory.
What the money is for
A build sized to contracts, most of them not yet earning. Akamai says it has signed more than $14B of multi-year commitments this year. The largest, disclosed on September 24, is an $11.6B commitment from Anthropic over seven years, with an option to expand by up to $9.00B; Akamai tied about $5.5B of capital spending to it. The chief financial officer said revenue from the more than $14B of contracts signed this year should begin ramping in the fourth quarter and reach about $2.2B a year once fully ramped by the end of 2028. CIS revenue was $109M in the third quarter, up 34% on a year earlier (35% at constant currency) and 9.7% of Akamai’s revenue; Akamai projects $1.1B–1.3B for 2027.
The spending lands first. Capital spending was $464M in the third quarter, 41% of revenue, up from $206M in the first. The fourth-quarter range, $2.45B–2.65B, is 71%–72% of the year’s total. Akamai held $4.24B of cash and marketable securities at September 30.
The new notes would sit between debt Akamai already owes in 2027, 2029 and later
Convertible senior notes by maturity, principal at face, $ billions, at June 30, 2026 (Q2 10-Q), and the two series proposed on November 9 (pink, with the dashed option of up to $150M each). The 2027 notes (faint grey) are the ones the offering would help repay. Conversion prices are per share; Akamai’s shares were at about $80.29 on November 9, below every existing conversion price.
The figures behind the charts
| Notes | Coupon % | Principal $M | Conversion price $ |
|---|---|---|---|
| Due 2027 | 0.375 | 1,150 | 116.18 |
| Due 2029 | 1.125 | 1,265 | 126.31 |
| Due 2030 | 0 | 1,750 | 201.41 |
| Due 2032 | 0 | 1,750 | 190.81 |
| Due 2033 | 0.25 | 1,725 | 93.01 |
| Due 2028, proposed | not set | 1,100 (+150) | not set |
| Due 2031, proposed | not set | 1,100 (+150) | not set |
| Capital spending | $M |
|---|---|
| 2024 | 675.9 |
| 2025 | 818 |
| Q1 2026 | 206.3 |
| Q2 2026 | 346.5 |
| Q3 2026 | 464.1 |
| Q4 2026, guidance | 2,445–2,645 |
| 2026, guidance | 3,462–3,662 |
The Anthropic commitment runs to as much as $20.6B with its option; CIS revenue is running at about $0.44B a year
$ billions. The Anthropic commitment runs over seven years; the dashed outline is the option to expand by up to $9B. “Fully ramped” is the chief financial officer’s estimate of yearly revenue from all the CIS contracts signed this year (more than $14B) once fully ramped by the end of 2028. CIS revenue for the third quarter times four is our arithmetic. Commitments are totals over several years; revenue and capex rows are per year.
What this changes on inthesingularity.ai
- Neocloud funding pack: Akamai is funding its cloud build largely with convertibles, $10.1B at face at most after this deal, against $4.24B of cash. Worth adding as a case once the notes price, with coupon and conversion premium.
- Anthropic S-1 pack: Akamai’s $11.6B over seven years, about $1.66B a year on average, is likely among the lab’s compute purchase commitments, and a warrant for up to about 5% of Akamai’s shares at $111.33 could give Anthropic a stake in its supplier.
- Worth tracking: whether Moody’s follows S&P below investment grade, and the pricing release, due within days.
Sources and method
| Item | Figure | Source |
|---|---|---|
| Offering | Proposed $1,100M of notes due Nov 15, 2028 and $1,100M due Nov 15, 2031, option for up to $150M more of each; to repay part of the $1,150M 0.375% notes due Sep 1, 2027, fund CIS capital spending, pay for note hedges net of warrants, and for general purposes; rates set at pricing | Akamai, 8-K Ex. 99.1, Nov 9 |
| Credit agreement | Amendment No. 4 (Nov 5) raises the maximum leverage ratio to 6.25× for Q4 2026 and Q1 2027, stepping down to 3.75× by Q1 2028 | Akamai, 8-K, Nov 9 |
| Ratings | S&P: BBB- to BB+, stable; leverage slightly above 4× in 2027. Moody’s: cut one notch to Baa3, stable; pro forma gross leverage above 7× | Investing.com, Nov 9 |
| Convertible notes | Five series at face, $7.64B in all, with coupons and conversion prices | Akamai, 10-Q for Q2 2026 |
| Q3 2026 | Revenue $1,122M; CIS $109M against $81M; capex $464.1M, nine months $1,017.0M; cash and marketable securities $4,239M; convertible notes carried at $1,148M current and $6,419M non-current; 2026 revenue guidance $4.440B–$4.465B; 2027 CIS $1.1B–$1.3B projected; more than $14B of commitments signed this year | Akamai, Q3 release, Nov 5 |
| Q3 call | Q4 capex $2.445B–$2.645B; full year $3.462B–$3.662B; about $1.7B in Q4 to pre-buy components, notably memory; about $2.2B a year of revenue from the more than $14B of contracts signed this year, fully ramped by end-2028 | Motley Fool transcript, Nov 6 |
| Capex 2026 | Q1 $206.3M; Q2 $346.5M | Akamai, Q1 and Q2 releases |
| Capex 2024–25 | $675.9M and $818.0M | Akamai, Q4 2025 release |
| Anthropic | $11.6B over seven years, option to expand by up to $9.00B; about $5.5B of capex tied to the deal; warrant at $111.33 a share | Akamai, 8-K, Sep 24 |
| May notes | $1.75B of 0% notes due 2030 and $1.75B due 2032 after the option | Akamai, 8-K, May 2026 |
| Shares | $80.29, down 3.37%, on Investing.com’s Nov 9 quote (time not shown); $83.09 GuruFocus pre-market price, Nov 9 | Investing.com; GuruFocus, Nov 9 |
The notes had not priced when this was written; sizes are the proposed amounts. Convertible principal by series is from the 10-Q for the quarter to June 30; the third-quarter release gives only carrying values ($1,148M current, $6,419M non-current). The rating actions come from Investing.com’s report; we have not seen the agencies’ notes. Capex guidance comes from the call, not the release. New notes: 1100 + 1100 = 2200; with both options + 300 = 2500. Face value: 1150 + 1265 + 1750 + 1750 + 1725 = 7640; + 2200 = 9840; with options 10140; less the 2027 notes, 8690. Capex: 206.3 + 346.5 + 464.1 = 1016.9, against 1017.0 reported for nine months, which we use; + 2445 = 3462.0 and + 2645 = 3662.0, matching the stated range; 3462 ÷ 818 = 4.23, 3662 ÷ 818 = 4.48; against revenue guidance, 3462 ÷ 4465 = 77.5%, 3662 ÷ 4440 = 82.5%; fourth-quarter share 2445 ÷ 3462 = 70.6%, 2645 ÷ 3662 = 72.2%; third quarter 464.1 ÷ 1122 = 41.4%. Fourth quarter against the past: 675.9 + 818 + 1017.0 = 2510.9, against 2445–2645. CIS: 108.8 ÷ 81.2 − 1 = 34.0%; 108.8 ÷ 1122 = 9.7%; × 4 = 435.2. Anthropic: 11600 ÷ 7 = 1657 a year. Shares: 80.29 ÷ 83.09 − 1 = -3.37%.
Wire reports are written within hours of the news, on a six-hour schedule. Each lists its sources and shows the arithmetic behind its figures. Not investment advice.